脑梗死急性期患者血浆纤维蛋白原和D-二聚体及抗凝血酶Ⅲ水平的变化

被引:22
作者
李娜 [1 ,2 ]
任长虹 [1 ]
孙菲 [3 ]
李宁 [1 ]
吉训明 [1 ]
机构
[1] 首都医科大学宣武医院低氧医学研究所
[2] 北京市仁和医院神经内科
[3] 北京市老年保健及疾病防治中心
关键词
脑梗死; 纤维蛋白原; 抗凝血酶Ⅲ; D-二聚体; 急性期;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
目的探讨脑梗死急性期患者血浆纤维蛋白原(FIB)、D-二聚体(DD)、抗凝血酶Ⅲ(ATⅢ)水平的变化。方法选择发病时间<24h的脑梗死患者95例作为脑梗死组。另选择同期体检者61例作为对照组。分别采用发色底物法、免疫比浊法、酶联免疫吸附法测定两组对象的血浆ATⅢ、FIB、DD的水平。将脑梗死组患者分为美国国立卫生研究院卒中量表评分(NIHSS)<5分组和5~19分组,分析ATⅢ、FIB、DD水平对脑梗死严重程度的影响。结果①脑梗死组FIB的水平为(3.1±0.9)g/L,DD为0.15(中位数)mg/L,高于对照组的(2.6±0.6)g/L和0.07mg/L;ATⅢ的水平为(101±11)%,低于对照组的(109±11)%。差异均有统计学意义,均P<0.01。脑梗死<12h组与脑梗死≥12h比较,FIB、DD、ATⅢ水平差异均无统计学意义。②在脑梗死组中,NIHSS<5分者的FIB、DD水平低于NIHSS5~19分者的水平,但差异无统计学意义;ATⅢ水平高于NIHSS5~19分者的水平[(105±11)%比(98±10)%],P<0.05。③多因素Logistic回归分析显示,DD(OR=8.489×103,95%CI:91.587~78.67×104)、FIB(OR=2.736,95%CI:1.446~5.176)水平升高、ATⅢ(OR=0.929,95%CI:0.877~0.984)水平降低是脑梗死的独立危险因素,P<0.01或P<0.05。结论 FIB、DD、ATⅢ在脑梗死急性期有明显变化。3者均是脑梗死的危险因素。ATⅢ可能是影响脑梗死严重程度的因素之一。
引用
收藏
页码:268 / 272
页数:5
相关论文
共 7 条
[1]   Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke [J].
Meng, Ran ;
Li, Zhi-Yong ;
Ji, Xunming ;
Ding, Yuchuan ;
Meng, Sui ;
Wang, Xiaoying .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (05) :380-386
[2]   Using ImageJ for the quantitative analysis of flow-based adhesion assays in real-time under physiologic flow conditions [J].
dos Santos, Sascha Meyer ;
Klinkhardt, Ute ;
Schneppenheim, Reinhard ;
Harder, Sebastian .
PLATELETS, 2010, 21 (01) :60-66
[3]  
Fibrinogen Independently Predicts the Development of Ischemic Stroke in a Taiwanese Population: CVDFACTS Study[J] . Shao-Yuan Chuang,Chyi-Huey Bai,Wei-Hung Chen,Li-Ming Lien,Wen-Harn Pan.Stroke . 2009 (5)
[4]  
Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review[J] . William Whiteley,Wei Li Chong,Anshuman Sengupta,Peter Sandercock.Stroke . 2009 (5)
[5]  
Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study[J] . Daniel T. Laskowitz,Scott E. Kasner,Jeffrey Saver,Kerri S. Remmel,Edward C. Jauch.Stroke . 2009 (1)
[6]   Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction [J].
Tombul, T ;
Atbas, C ;
Anlar, O .
JOURNAL OF CLINICAL NEUROSCIENCE, 2005, 12 (04) :429-434
[7]  
Anticoagulant Therapy with a Selective Thrombin Inhibitor for Acute Cerebral Infarction: Usefulness of Coagulation Markers for Evaluation of Efficacy[J] . Takao Urabe,Ryota Tanaka,Kazuyuki Noda,Yoshikuni Mizuno.Journal of Thrombosis and Thrombolysis . 2002 (3)